Evidence of transcriptional and translational components in anti-ischemic effects of adenosine

John P. Headrick, Jason Peart, Kirsten Holmgren, Kevin Ashton

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Abstract

Adenosine protects against myocardial ischemic injury via poorly defined mechanisms. We examined effects of inhibition of gene transcription, mRNA translation, and mitochondrial KATP channels on cardioprotective effects of adenosine in mouse hearts subjected to 20-min ischemia. Adenosine treatment reduced postischemic lactate dehydrogenase efflux (indicating necrosis) from 24 ± 2 to 9 ± 1 IU/g, and postischemic diastolic contracture from 21 ± 2 to 5 ± 2 mm Hg, and enhanced postischemic ventricular pressure development from 72 ± 3 to 135 ± 4 mm Hg. The antinecrotic response was reduced ≈50% by inhibition of protein translation (10 μM cycloheximide, CHX), unaltered by inhibition of transcription (20 μM actinomycin D, Act-D), and abrogated by mitochondrial KATP channel inhibition (100 μM 5-hydroxydecanoate, 5-HD). In contrast, protection against contractile dysfunction was reduced but not eliminated by CHX, Act-D, and 5-HD, and inhibitory effects CHX and Act-D were not additive with those of 5-HD, supporting a common mechanistic path. Inhibitory effects of Act-D were mimicked by 1.5 μM α-amanitin. These data provide evidence that adenosine limits necrosis in a mito KATP channel-dependent manner involving protein translation. The translational component is not dependent upon mRNA transcription. Adenosine also substantially reduces contractile dysfunction via a pathway involving mitochondrial KATP channel activation, protein translation, and mRNA transcription. Protection independent of this path was also evident. Thus, distinct signaling pathways appear to be involved in adenosine-mediated protection against postischemic necrosis and contractile dysfunction.

Original languageEnglish
Pages (from-to)454-460
Number of pages7
JournalDrug Development Research
Volume58
Issue number4
DOIs
Publication statusPublished - 1 Apr 2003
Externally publishedYes

Fingerprint

Adenosine
Protein Biosynthesis
Dactinomycin
Transcription
Cycloheximide
Necrosis
Messenger RNA
Amanitins
KATP Channels
Proteins
Contracture
Ventricular Pressure
L-Lactate Dehydrogenase
Ischemia
Genes
Chemical activation
Wounds and Injuries
mitochondrial K(ATP) channel
5-hydroxydecanoic acid

Cite this

Headrick, John P. ; Peart, Jason ; Holmgren, Kirsten ; Ashton, Kevin. / Evidence of transcriptional and translational components in anti-ischemic effects of adenosine. In: Drug Development Research. 2003 ; Vol. 58, No. 4. pp. 454-460.
@article{9176e571bd2d47b1846b38a370eb0df0,
title = "Evidence of transcriptional and translational components in anti-ischemic effects of adenosine",
abstract = "Adenosine protects against myocardial ischemic injury via poorly defined mechanisms. We examined effects of inhibition of gene transcription, mRNA translation, and mitochondrial KATP channels on cardioprotective effects of adenosine in mouse hearts subjected to 20-min ischemia. Adenosine treatment reduced postischemic lactate dehydrogenase efflux (indicating necrosis) from 24 ± 2 to 9 ± 1 IU/g, and postischemic diastolic contracture from 21 ± 2 to 5 ± 2 mm Hg, and enhanced postischemic ventricular pressure development from 72 ± 3 to 135 ± 4 mm Hg. The antinecrotic response was reduced ≈50{\%} by inhibition of protein translation (10 μM cycloheximide, CHX), unaltered by inhibition of transcription (20 μM actinomycin D, Act-D), and abrogated by mitochondrial KATP channel inhibition (100 μM 5-hydroxydecanoate, 5-HD). In contrast, protection against contractile dysfunction was reduced but not eliminated by CHX, Act-D, and 5-HD, and inhibitory effects CHX and Act-D were not additive with those of 5-HD, supporting a common mechanistic path. Inhibitory effects of Act-D were mimicked by 1.5 μM α-amanitin. These data provide evidence that adenosine limits necrosis in a mito KATP channel-dependent manner involving protein translation. The translational component is not dependent upon mRNA transcription. Adenosine also substantially reduces contractile dysfunction via a pathway involving mitochondrial KATP channel activation, protein translation, and mRNA transcription. Protection independent of this path was also evident. Thus, distinct signaling pathways appear to be involved in adenosine-mediated protection against postischemic necrosis and contractile dysfunction.",
author = "Headrick, {John P.} and Jason Peart and Kirsten Holmgren and Kevin Ashton",
year = "2003",
month = "4",
day = "1",
doi = "10.1002/ddr.10179",
language = "English",
volume = "58",
pages = "454--460",
journal = "Drug Development Research",
issn = "0272-4391",
publisher = "John Wiley & Sons",
number = "4",

}

Evidence of transcriptional and translational components in anti-ischemic effects of adenosine. / Headrick, John P.; Peart, Jason; Holmgren, Kirsten; Ashton, Kevin.

In: Drug Development Research, Vol. 58, No. 4, 01.04.2003, p. 454-460.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Evidence of transcriptional and translational components in anti-ischemic effects of adenosine

AU - Headrick, John P.

AU - Peart, Jason

AU - Holmgren, Kirsten

AU - Ashton, Kevin

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Adenosine protects against myocardial ischemic injury via poorly defined mechanisms. We examined effects of inhibition of gene transcription, mRNA translation, and mitochondrial KATP channels on cardioprotective effects of adenosine in mouse hearts subjected to 20-min ischemia. Adenosine treatment reduced postischemic lactate dehydrogenase efflux (indicating necrosis) from 24 ± 2 to 9 ± 1 IU/g, and postischemic diastolic contracture from 21 ± 2 to 5 ± 2 mm Hg, and enhanced postischemic ventricular pressure development from 72 ± 3 to 135 ± 4 mm Hg. The antinecrotic response was reduced ≈50% by inhibition of protein translation (10 μM cycloheximide, CHX), unaltered by inhibition of transcription (20 μM actinomycin D, Act-D), and abrogated by mitochondrial KATP channel inhibition (100 μM 5-hydroxydecanoate, 5-HD). In contrast, protection against contractile dysfunction was reduced but not eliminated by CHX, Act-D, and 5-HD, and inhibitory effects CHX and Act-D were not additive with those of 5-HD, supporting a common mechanistic path. Inhibitory effects of Act-D were mimicked by 1.5 μM α-amanitin. These data provide evidence that adenosine limits necrosis in a mito KATP channel-dependent manner involving protein translation. The translational component is not dependent upon mRNA transcription. Adenosine also substantially reduces contractile dysfunction via a pathway involving mitochondrial KATP channel activation, protein translation, and mRNA transcription. Protection independent of this path was also evident. Thus, distinct signaling pathways appear to be involved in adenosine-mediated protection against postischemic necrosis and contractile dysfunction.

AB - Adenosine protects against myocardial ischemic injury via poorly defined mechanisms. We examined effects of inhibition of gene transcription, mRNA translation, and mitochondrial KATP channels on cardioprotective effects of adenosine in mouse hearts subjected to 20-min ischemia. Adenosine treatment reduced postischemic lactate dehydrogenase efflux (indicating necrosis) from 24 ± 2 to 9 ± 1 IU/g, and postischemic diastolic contracture from 21 ± 2 to 5 ± 2 mm Hg, and enhanced postischemic ventricular pressure development from 72 ± 3 to 135 ± 4 mm Hg. The antinecrotic response was reduced ≈50% by inhibition of protein translation (10 μM cycloheximide, CHX), unaltered by inhibition of transcription (20 μM actinomycin D, Act-D), and abrogated by mitochondrial KATP channel inhibition (100 μM 5-hydroxydecanoate, 5-HD). In contrast, protection against contractile dysfunction was reduced but not eliminated by CHX, Act-D, and 5-HD, and inhibitory effects CHX and Act-D were not additive with those of 5-HD, supporting a common mechanistic path. Inhibitory effects of Act-D were mimicked by 1.5 μM α-amanitin. These data provide evidence that adenosine limits necrosis in a mito KATP channel-dependent manner involving protein translation. The translational component is not dependent upon mRNA transcription. Adenosine also substantially reduces contractile dysfunction via a pathway involving mitochondrial KATP channel activation, protein translation, and mRNA transcription. Protection independent of this path was also evident. Thus, distinct signaling pathways appear to be involved in adenosine-mediated protection against postischemic necrosis and contractile dysfunction.

UR - http://www.scopus.com/inward/record.url?scp=0038726881&partnerID=8YFLogxK

U2 - 10.1002/ddr.10179

DO - 10.1002/ddr.10179

M3 - Article

VL - 58

SP - 454

EP - 460

JO - Drug Development Research

JF - Drug Development Research

SN - 0272-4391

IS - 4

ER -